Trial Profile
A Trial to Test for Bioequivalence Between Identical NN1250 Formulations, IM1 and IM2, in Healthy Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 29 Nov 2013
Price :
$35
*
At a glance
- Drugs Insulin degludec (Primary)
- Indications Type 1 diabetes mellitus; Type 2 diabetes mellitus
- Focus Pharmacokinetics
- 29 Nov 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 10 Sep 2010 New trial record